Haemonetics Corp

Common Name

Haemonetics

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

3,657

Ticker

HAE

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.haemonetics.com

Description

Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthca... Show more

Income Statement Balance Sheet Group Entities

Haemonetics's Financial Statements Preview

Below are the financial statements of Haemonetics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-03-30	2023 as of 2023-04-01
Assets	—	—
Current assets	—	—
Cash and cash equivalents	178.8^a	284.47^a
Accounts receivable, less allowance for credit losses of $5,695 at March 30, 2024 and $4,932 at April 1, 2023	206.56^a	179.14^a
Inventories, net	317.2^a	259.38^a
Prepaid expenses and other current assets	66.34^a	46.74^a
Total current assets	768.9^a	769.72^a
Property, plant and equipment, net	311.36^a	310.89^a
Intangible assets, less accumulated amortization of $455,213 at March 30, 2024 and $417,422 at April 1, 2023	406.12^a	275.77^a
Goodwill	565.08^a	466.23^a
Deferred tax asset	7.74^a	5.24^a
Other long-term assets	136.39^a	106.98^a
Total assets	2,195.59^a	1,934.83^a
Liabilities and stockholders’ equity	—	—
Current liabilities	—	—
Notes payable and current maturities of long-term debt	10.23^a	11.78^a
Accounts payable	73.36^a	63.93^a
Accrued payroll and related costs	80.71^a	64.48^a
Other current liabilities	136.09^a	111.63^a
Total current liabilities	300.38^a	251.82^a
Long-term debt, net of current maturities	797.56^a	754.1^a
Deferred tax liability	62.64^a	36.2^a
Other long-term liabilities	75.04^a	74.72^a
Stockholders’ equity	—	—
Common stock	0.51^a	0.5^a
Additional paid-in capital	634.63^a	594.71^a
Retained earnings	360.46^a	253.17^a
Accumulated other comprehensive loss	-35.63^a	-30.38^a
Total stockholders’ equity	959.96^a	818^a
Total liabilities and stockholders’ equity	2,195.59^a	1,934.83^a

Download Data

Verified Sources Behind Haemonetics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Haemonetics’s data sources below and access millions more through our Disclosure Search.

a. Haemonetics's 10-K 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Haemonetics Corp

Haemonetics's Financial Statements Preview

Verified Sources Behind Haemonetics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Transmedics Group Inc

Globus Medical Inc

Zimmer Biomet Holdings Inc

Stryker Corp

Procept Biorobotics Corp

Masimo Corp